Roivant Sciences Ltd.
ROIV · FY2026 · Fiscal year ended Mar 31, 2026 · 10-K filed May 2026
Open the dashboardInfographicSummary
FY2026 key figures
| $ | FY2026 | FY2025 | Change |
|---|---|---|---|
| Revenue | $8.26M | $29.1M | −71.6% |
| Operating income | −$515M | −$1.00B | +48.7% |
| Net income | −$300M | −$172M | −74.3% |
Latest quarter: Q2 FY2027
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026
| $ | Q2 FY2027 | Year earlier | Change |
|---|---|---|---|
| Revenue | $35.1M | $1.60M | +2,094% |
| Operating income | −$268M | −$306M | +12.5% |
| Net income | −$192M | −$114M | −68.8% |
Q2 FY2027 dashboardQ2 FY2027 infographic
Questions
- What was Roivant's revenue in FY2026?
- $8.26M in FY2026 (Fiscal year ended Mar 31, 2026), −71.6% vs $29.1M a year earlier, per its 10-K filed May 2026.
- Was Roivant profitable in FY2026?
- No: net income was −$300M and operating income −$515M in FY2026.
- What was Roivant's revenue in Q2 FY2027?
- $35.1M (+2,094% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.